BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36965046)

  • 21. FGFR3 gene mutations in Chinese cases of thanatophoric dysplasia type 1.
    Yang Y; Li DZ
    Fetal Diagn Ther; 2009; 26(2):90-2. PubMed ID: 19752524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical achondroplasia due to somatic mosaicism for the common thanatophoric dysplasia mutation R248C.
    Takagi M; Kaneko-Schmitt S; Suzumori N; Nishimura G; Hasegawa T
    Am J Med Genet A; 2012 Jan; 158A(1):247-50. PubMed ID: 22106050
    [No Abstract]   [Full Text] [Related]  

  • 23. Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation.
    De Biasio P; Prefumo F; Baffico M; Baldi M; Priolo M; Lerone M; Tomà P; Venturini PL
    Prenat Diagn; 2000 Oct; 20(10):835-7. PubMed ID: 11038465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thanatophoric dysplasia type I with syndactyly.
    Brodie SG; Kitoh H; Lipson M; Sifry-Platt M; Wilcox WR
    Am J Med Genet; 1998 Nov; 80(3):260-2. PubMed ID: 9843049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chylous Ascites in an Infant with Thanatophoric Dysplasia Type I with FGFR3 Mutation Surviving Five Months.
    Soo-Kyeong J; Lee N; Bae MH; Han YM; Hee Park K; Byun SY
    Fetal Pediatr Pathol; 2018 Oct; 37(5):363-371. PubMed ID: 30252581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype.
    Camera G; Baldi M; Strisciuglio G; Concolino D; Mastroiacovo P; Baffico M
    Am J Med Genet; 2001 Dec; 104(4):277-81. PubMed ID: 11754059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual radiological finding in thanatophoric dysplasia type 1 with common mutation of the fibroblast growth factor receptor-3 (FGFR3) gene (Arg248Cys).
    Camera G; Baldi M; Baffico M; Pozzolo S
    Am J Med Genet; 1997 Jul; 71(1):122-3. PubMed ID: 9215781
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.
    Terasawa S; Kato A; Nishizawa H; Kato T; Yoshizawa H; Noda Y; Miyazaki J; Ito M; Sekiya T; Fujii T; Kurahashi H
    Congenit Anom (Kyoto); 2019 Jan; 59(1):4-10. PubMed ID: 29542187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia.
    Chen CP; Chern SR; Shih JC; Wang W; Yeh LF; Chang TY; Tzen CY
    Prenat Diagn; 2001 Feb; 21(2):89-95. PubMed ID: 11241532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thanatophoric dysplasia: roentgenographic findings and detection of a de novo mutation of FGFR3 gene in a Thai patient.
    Wattanasirichaigoon D; Charoenpipop D
    J Med Assoc Thai; 2006 Aug; 89(8):1287-92. PubMed ID: 17048442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I.
    Tavormina PL; Rimoin DL; Cohn DH; Zhu YZ; Shiang R; Wasmuth JJ
    Hum Mol Genet; 1995 Nov; 4(11):2175-7. PubMed ID: 8589699
    [No Abstract]   [Full Text] [Related]  

  • 32. Prenatal diagnosis and molecular analysis of type 1 thanatophoric dysplasia.
    Li D; Liao C; Ma X
    Int J Gynaecol Obstet; 2005 Dec; 91(3):268-70. PubMed ID: 16214145
    [No Abstract]   [Full Text] [Related]  

  • 33. Orthopaedic Manifestations of Thanatophoric Dwarfism: A Case Report.
    DeGenova DT; Wing AO; Perugini AJ; Petersen MJ; Misbrener E; Tulchin-Francis K; Kadado A
    JBJS Case Connect; 2023 Jul; 13(3):. PubMed ID: 37499053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGFR3 mutation in thanatophoric dysplasia type 1 with bilateral cystic renal dysplasia: coincidence or a new association?
    Prontera P; Sensi A; Pilu G; Baldi M; Baffico M; Bonasoni R; Calzolari E
    Genet Couns; 2006; 17(4):407-12. PubMed ID: 17375526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early ultrasound suspect of thanatophoric dysplasia followed by first trimester molecular diagnosis.
    Giancotti A; Castori M; Spagnuolo A; Binni F; D'Ambrosio V; Pasquali G; Pizzuti A; Grammatico P
    Am J Med Genet A; 2011 Jul; 155A(7):1756-8. PubMed ID: 21671381
    [No Abstract]   [Full Text] [Related]  

  • 36. Second trimester molecular diagnosis of a stop codon FGFR3 mutation in a type I thanatophoric dysplasia fetus following abnormal ultrasound findings.
    Chen CP; Chern SR; Chang TY; Lin CJ; Wang W; Tzen CY
    Prenat Diagn; 2002 Aug; 22(8):736-7. PubMed ID: 12210587
    [No Abstract]   [Full Text] [Related]  

  • 37. Seborrhoeic keratoses and acanthosis nigricans in a long-term survivor of thanatophoric dysplasia.
    Nakai K; Yoneda K; Moriue T; Munehiro A; Fujita N; Moriue J; Yokoi I; Haba R; Itoh S; Kubota Y
    Br J Dermatol; 2010 Sep; 163(3):656-8. PubMed ID: 20518778
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thanatophoric dysplasia].
    Tonoki H
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):294-5. PubMed ID: 11057234
    [No Abstract]   [Full Text] [Related]  

  • 39. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1.
    Rousseau F; Saugier P; Le Merrer M; Munnich A; Delezoide AL; Maroteaux P; Bonaventure J; Narcy F; Sanak M
    Nat Genet; 1995 May; 10(1):11-2. PubMed ID: 7647778
    [No Abstract]   [Full Text] [Related]  

  • 40. Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I.
    d'Avis PY; Robertson SC; Meyer AN; Bardwell WM; Webster MK; Donoghue DJ
    Cell Growth Differ; 1998 Jan; 9(1):71-8. PubMed ID: 9438390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.